182 related articles for article (PubMed ID: 29581158)
1. Chymase released from hypoxia-activated cardiac mast cells cleaves human apoA-I at Tyr
Kareinen I; Baumann M; Nguyen SD; Maaninka K; Anisimov A; Tozuka M; Jauhiainen M; Lee-Rueckert M; Kovanen PT
J Lipid Res; 2018 Jun; 59(6):945-957. PubMed ID: 29581158
[TBL] [Abstract][Full Text] [Related]
2. Carboxyl-Terminal Cleavage of Apolipoprotein A-I by Human Mast Cell Chymase Impairs Its Anti-Inflammatory Properties.
Nguyen SD; Maaninka K; Lappalainen J; Nurmi K; Metso J; Öörni K; Navab M; Fogelman AM; Jauhiainen M; Lee-Rueckert M; Kovanen PT
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):274-84. PubMed ID: 26681753
[TBL] [Abstract][Full Text] [Related]
3. Identification of domains in apoA-I susceptible to proteolysis by mast cell chymase. Implications for HDL function.
Lee M; Uboldi P; Giudice D; Catapano AL; Kovanen PT
J Lipid Res; 2000 Jun; 41(6):975-84. PubMed ID: 10828090
[TBL] [Abstract][Full Text] [Related]
4. Identification of sites in apolipoprotein A-I susceptible to chymase and carboxypeptidase A digestion.
Usami Y; Kobayashi Y; Kameda T; Miyazaki A; Matsuda K; Sugano M; Kawasaki K; Kurihara Y; Kasama T; Tozuka M
Biosci Rep; 2012 Dec; 33(1):49-56. PubMed ID: 23072735
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein composition and particle size affect HDL degradation by chymase: effect on cellular cholesterol efflux.
Lee M; Kovanen PT; Tedeschi G; Oungre E; Franceschini G; Calabresi L
J Lipid Res; 2003 Mar; 44(3):539-46. PubMed ID: 12562834
[TBL] [Abstract][Full Text] [Related]
6. Mast cell chymase degrades apoE and apoA-II in apoA-I-knockout mouse plasma and reduces its ability to promote cellular cholesterol efflux.
Lee M; Calabresi L; Chiesa G; Franceschini G; Kovanen PT
Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1475-81. PubMed ID: 12231569
[TBL] [Abstract][Full Text] [Related]
7. Characterization of novel truncated apolipoprotein A-I in human high-density lipoprotein generated by sequential treatment with myeloperoxidase and chymase.
Lai SJ; Kameda T; Morita M; Yamagata Y; Nishizaka K; Horiuchi Y; Kobayashi Y; Usami Y; Liu JJ; Kasama T; Tozuka M; Ohkawa R
Biochimie; 2024 Mar; 218():34-45. PubMed ID: 37774825
[TBL] [Abstract][Full Text] [Related]
8. Detection of chymase-digested C-terminally truncated apolipoprotein A-I in normal human serum.
Usami Y; Matsuda K; Sugano M; Ishimine N; Kurihara Y; Sumida T; Yamauchi K; Tozuka M
J Immunol Methods; 2011 Jun; 369(1-2):51-8. PubMed ID: 21497162
[TBL] [Abstract][Full Text] [Related]
9. Development of a new bioactivatable fluorescent probe for quantification of apolipoprotein A-I proteolytic degradation in vitro and in vivo.
Maafi F; Li B; Gebhard C; Brodeur MR; Nachar W; Villeneuve L; Lesage F; Rhainds D; Rhéaume E; Tardif JC
Atherosclerosis; 2017 Mar; 258():8-19. PubMed ID: 28167355
[TBL] [Abstract][Full Text] [Related]
10. Depletion of pre beta 1LpA1 and LpA4 particles by mast cell chymase reduces cholesterol efflux from macrophage foam cells induced by plasma.
Lee M; von Eckardstein A; Lindstedt L; Assmann G; Kovanen PT
Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):1066-74. PubMed ID: 10195937
[TBL] [Abstract][Full Text] [Related]
11. GPR30 decreases cardiac chymase/angiotensin II by inhibiting local mast cell number.
Zhao Z; Wang H; Lin M; Groban L
Biochem Biophys Res Commun; 2015 Mar; 459(1):131-6. PubMed ID: 25712524
[TBL] [Abstract][Full Text] [Related]
12. Activated mast cells induce endothelial cell apoptosis by a combined action of chymase and tumor necrosis factor-alpha.
Heikkilä HM; Lätti S; Leskinen MJ; Hakala JK; Kovanen PT; Lindstedt KA
Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):309-14. PubMed ID: 18079408
[TBL] [Abstract][Full Text] [Related]
13. Production of proteolytic enzymes in mast cells, fibroblasts, vascular smooth muscle and endothelial cells cultivated under normoxic or hypoxic conditions.
Maxová H; Bačáková L; Lisá V; Novotná J; Tomášová H; Vízek M; Herget J
Physiol Res; 2010; 59(5):711-719. PubMed ID: 20406036
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine 192 in apolipoprotein A-I is the major site of nitration and chlorination by myeloperoxidase, but only chlorination markedly impairs ABCA1-dependent cholesterol transport.
Shao B; Bergt C; Fu X; Green P; Voss JC; Oda MN; Oram JF; Heinecke JW
J Biol Chem; 2005 Feb; 280(7):5983-93. PubMed ID: 15574409
[TBL] [Abstract][Full Text] [Related]
15. Human macrophage cathepsin B-mediated C-terminal cleavage of apolipoprotein A-I at Ser228 severely impairs antiatherogenic capacity.
Dinnes DL; White MY; Kockx M; Traini M; Hsieh V; Kim MJ; Hou L; Jessup W; Rye KA; Thaysen-Andersen M; Cordwell SJ; Kritharides L
FASEB J; 2016 Dec; 30(12):4239-4255. PubMed ID: 27630170
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II generation by mast cell alpha- and beta-chymases.
Caughey GH; Raymond WW; Wolters PJ
Biochim Biophys Acta; 2000 Jul; 1480(1-2):245-57. PubMed ID: 10899625
[TBL] [Abstract][Full Text] [Related]
17. Mast cell-dependent proteolytic modification of HDL particles during anaphylactic shock in the mouse reduces their ability to induce cholesterol efflux from macrophage foam cells ex vivo.
Judström I; Jukkola H; Metso J; Jauhiainen M; Kovanen PT; Lee-Rueckert M
Atherosclerosis; 2010 Jan; 208(1):148-54. PubMed ID: 19679305
[TBL] [Abstract][Full Text] [Related]
18. Chymase in exocytosed rat mast cell granules effectively proteolyzes apolipoprotein AI-containing lipoproteins, so reducing the cholesterol efflux-inducing ability of serum and aortic intimal fluid.
Lindstedt L; Lee M; Castro GR; Fruchart JC; Kovanen PT
J Clin Invest; 1996 May; 97(10):2174-82. PubMed ID: 8636396
[TBL] [Abstract][Full Text] [Related]
19. Extended cleavage specificities of mast cell proteases 1 and 2 from golden hamster: Classical chymase and an elastolytic protease comparable to rat and mouse MCP-5.
Thorpe M; Fu Z; Albat E; Akula S; de Garavilla L; Kervinen J; Hellman L
PLoS One; 2018; 13(12):e0207826. PubMed ID: 30521603
[TBL] [Abstract][Full Text] [Related]
20. Disruption in the balance between apolipoprotein A-I and mast cell chymase in chronic hypersensitivity pneumonitis.
Inoue Y; Okamoto T; Honda T; Nukui Y; Akashi T; Takemura T; Tozuka M; Miyazaki Y
Immun Inflamm Dis; 2020 Dec; 8(4):659-671. PubMed ID: 33016012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
